RAPT Therapeutics, Inc. Gains 115.51%
Mon, Jun 14, 2021 at 05:30 PM
RAPT Therapeutics, Inc. (RAPT:NASDAQ) shot up at $40.02, a gain of 115.5%. The stock got featured on our News Catalysts scanner on Mon, Jun 14, 2021 at 05:01 PM in the 'PUBLIC OFFERING' category. From Fri, May 28, 2021, the stock recorded 55.56% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About RAPT Therapeutics, Inc. (RAPT:NASDAQ)
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Top 10 Gainers:
- RAPT Therapeutics, Inc. (RAPT:NASDAQ), 115.51%
- LXEH (LXEH:NASDAQ), 51.33%
- Mediaco Holding Inc. (MDIA:NASDAQ), 45.83%
- Nxt-ID, Inc. (NXTD:NASDAQ), 41.22%
- ITOS (ITOS:NASDAQ), 37.29%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 35.42%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 26.69%
- Luokung Technology Corp. (LKCO:NASDAQ), 26.55%
- AXT, Inc. (AXTI:NASDAQ), 20.59%
- ORPH (ORPH:NASDAQ), 19.08%